Outcomes 2017 - Baylor Heart and Vascular Services FY2017 | Page 88

Cardiovascular Related Publications

MEASURING INNOVATION IN HEART AND VASCULAR CARE
Myocardial Sympathetic Innervation as Evaluated by Cardiac I-123 mIBG Imaging? World Journal of Nuclear Science and Technology. 2016 July.
66. Muller DWM, Farivar RS, Jansz P, Bae R, Walters R, Clarke A, Grayburn PA, Stoler RC, Dahle G, Rein KA, Shaw M, Scalia GM, Guerrero M, Pearson P, Kapadia S, Gillinov M, Pichard A, Corso P, Popma J, Chuang M, Blanke P, Leipsic J, Sorajja P. Transcatheter Mitral Valve Replacement for Patients with Symptomatic Mitral Regurgitation. Journal of the American College of Cardiology Jan 2017; 69( 4): 381-391.
67. Nadruz W Jr, Claggett BL, McMurray JJ, Packer M, Zile MR, Rouleau JL, Desai AS, Swedberg K, Lefkowitz M, Shi VC, Prescott MF, Solomon SD.
Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study( Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial). Circulation. 2016 Nov 29; 134( 22): 1785-1787.
68. Nguyen HL, Yarzebski J, Lessard D, Gore JM, McManus DD, Goldberg RJ. Ten-year( 2001-2011) trends in the incidence rates and short-term outcomes of early versus late onset cardiogenic shock after hospitalization for acute myocardial infarction. Journal of the American Heart Association Jun 2017; 6( 6): e005566.
69. Nickenig G, Hammerstingl C, Schueler R, Topilsky Y, Grayburn PA, Vahanian A, Messika-Zeitoun D, Urena Alcazar M, Baldus S, Volker R, Huntgeburth M, Alfieri O, Latib A, La Canna G, Agricola E, Colombo A, Kuck KH, Kreidel F, Frerker C, Tanner FC, Ben-Yehuda O, Maisano F. Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System. JACC: Cardiovascular Interns. 2016 Oct 10; 9( 19): 2039-2047.
70. O’ Hair DP, Bajwa TK, Chetcuti SJ, Deeb GM, Stoler RC, Hebeler RF, Maini B, Mumtaz M, Kleiman NS, Reardon MJ, Li S, Adams DH, Watson DR, Yakubov SJ, Popma JJ, Petrossian G. One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. The Annals of Thoracic Surgery May 2017; 103( 5): 1392-1398.
71. Okumura N, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJ; PARADIGM- HF Investigators and Committees *. Effects of Sacubitril / Valsartan in the PARADIGM-HF Trial( Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy. Circulation Heart Failure. 2016 Sep; 9( 9).
72. Packer M, Armstrong WM, Rothstein JM, Emmett M. Sacubitril-Valsartan in Heart Failure. Annals of Internal Medicine May 2017; 166( 9): 681-682.
73. Packer M, Holcomb R, Abraham WT, Anker S, Dickstein K, Filippatos G, Krum H, Maggioni AP, McMurray JJV, Mebazaa A, O’ Conner C, Peacock F, Ponikowski P, Ruschitzka F, van Veldhuisen DJ, Holzmeister J, TRUE-AHF Investigators and Committtees. Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure. European Journal of Heart Failure May 2017; 19( 5): 673-681.
74. Packer M, McMurray JJV, Krum H, Kiowski W, Massie BM, Caspi A, Pratt CM, Petrie MC, DeMets D, Kobrin I, Roux S, Swedberg K, ENABLE Investigators and Committees. Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients with Severe Chronic Heart Failure: Primary Results of the ENABLE Trials. JACC Heart Failure May 2017; 5( 5): 317-326.
75. Packer M, McMurray JJV. Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the reninangiotensis system for the treatment of heart failure. Lancet May 2017; 389( 10081): 1831-1840.
76. Packer M, O’ Connor C, McMurray JJ, Wittes J, Abraham WT, Anker SD, Dickstein K, Fillppatos G, Holcomb R, Krum H, Maggioni AP, Mebazzaa A, Peacock WF, Petrie MC, Ponikowski P, Ruschitzka F, van Veldhuisen DJ, Kowarski LS, Schactman M, Holzmeister J, TRUE-AHF Investigators. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. New England Journal of Medicine May 2017; 376( 20): 1956-1964.
77. Packer M, Pitt B, Rouleau JL, Swedberg K, DeMets DL, Fisher L. Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients with Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years. JACC: Heart Failure Jun 2017; 5( 6): 399-407.
78. Packer M. Double Vision: Replicating a Trial Showing a Survival Benefit. JACC Heart Failure Mar 2017; 5( 3): 232-235.
79. Packer M. Heart Failure’ s Dark Secret: Does Anyone Really Care About Optimal Medical Therapy? Circulation. 2016 Aug 30; 134( 9): 629-31.
80. Packer M. Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril / valsartan in the USA. European Journal of Heart Failure. 2016 Oct; 18( 10): 1211-1219.
81. Packer M. Response by Dr. Packer to the Letter of Dr. Blankfield. Journal of Cardiovascular Pharmacology and Therapeutics Jan 2017; Epub.
82. Packer M. Response by Packer to Letter Regarding Article,“ Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective”. Circulation Apr 2017; 135( 15): e892-e893.
83. Packer M. Should recommendations for clinical use be restricted to patients who were enrolled in a pivotal clinical trial? European Journal of Heart Failure Jun 2017; 19( 6): 779-781.
84. Packer M. Tetralogy of Fallow: Four Trials and Tribulations. JACC: Heart Failure Jun 2017; 5( 6): 408-410.
85. Packer M. Angiotensin Neprilysin Inhibition for Patients With Heart Failure: What If Sacubitril / Valsartan Were a Treatment for Cancer? Jama Cardiology. 2016 Dec 1; 1( 9): 971-972.
86. Packer M. Cobalt Cardiomyopathy: A Critical Reappraisal in Light of a Recent Resurgence. Circulation Heart Failure. 2016 Dec; 9( 12).
87. Packer M. Data Sharing: lessons from Copernicus and Kepler. BMJ Sept 2016; 354: i4911.
88. Packer M. Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective. Circulation. 2016 Nov 22; 134( 21): 1664- 1678.
89. Packer M. Let Us Not Forget the Long-term Safety Concerns of Sacubitril / Valsartan-Reply. JAMA Cardiology Mar 2017; Epub.
90. Packer M. The Room Where it Happens: A Skeptic’ s Analysis of the New Heart Failure Guidlelines. Journal of Cardiac Failure. 2016 Sep; 22( 9): 726-30.
91. Parsa P, Eidt J, Rios A, Gable D, Vasquez J Jr. Case Report: An Innovative Endovascular Technique for Repair of Descending Thoracic Aortic Aneurysm following an Open Coarctation Repair. Annals of Vascular Surgery. 2017 May 4.
92. Parsa P, Rios A, Cantu K, Eidt J, Gable D, Pearl G. Case Report: A Durable Open Repair Of A Rare Profunda Aneurysm. Annals of Vascular Surgery. 2017 Jun 7.
93. Patankar GR, Grayburn PA, Hebeler RF Jr, Henry AC, Stoler RC. Avulsion of Aortic Leaflet During Transcatheter Aortic Valve Replacement. Journal of Interventional Cardiology. 2016 Oct; 29( 5): 549-551. Epub 2016 Aug 17.
94. Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, Smith PK. ACC / AATS / AHA / ASE / ASNC / SCAI / SCCT / STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients with Acute Coronary Syndromes. Journal of the American College of Cardiology Feb 2017; 69( 5): 570-591.
95. Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, Smith PK. ACC / AATS / AHA / ASE / ASNC / SCAI / SCCT / STS 2017 Appropriate Use Criterial for Coronary Revascularization in Patients with Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. Journal of the American College of Cardiology May 2017; 69( 17): 2212-2241.
96. Piccini JP, Stromberg K, Jackson KP, Laager V, Durray GZ, El-Chami M, Ellis CR, Hummel J, Jones DR, Kowal RC, Narasimhan C, Omar R, Ritter P, Roberts PR, Soejima K, Zhang S, Reynolds D, Micra Transcatheter Pacing Study Group. Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial. Heart Rhythm May 2017; 14( 5): 685-691.
97. Prasad A, Sohn A, Morales J, Williams K, Bailey SR, Levin D, McCullough PA, Mehran R, Lopez-Cruz G, Harder J. Contemporary Practice Pattern Related to the Risk of Acute Kidney Injury in the Catherization Laboratory: Results from a Survey of Society of Cardiovascular Angiography and Intervention( SCAI) Cardiologists. Catheterization Cardiovascular Interventions Feb 2017; 89( 3): 383-392.
98. Raza FS, Grayburn PA, Choi JW. Use of MitraClip for severe mitral regurgitation in a cardiac transplant patient. Proceedings Baylor University Medical Center Apr 2017; 30( 2): 226-227.
99. Reynolds MC, Carey SA, Driver S, Ko J, Felius J, Roberts WC, Hall SA. Patient acceptance of the Heart-to-Heart program: Using patients ' native hearts to promote post-transplant health. The Journal of Heart and Lung Transplantation. 2016 Oct; 35( 10): 1270-1271. Epub 2016 Jun 24.
100. Rich JD, Gosev I, Patel CB, Joseph S, Katz JN, Eckman PM, Lee S, Sundareswaran K, Kilic A, Bethea B, Soleimani B, Lima B, Uriel N, Kiernan M, Evolving Mechanical Support Research Group( EMERG) Investigators. The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. The Journal of Heart and Lung Transplantation Jan 2017; 36( 1): 50-58.
101. Roberts WC, Grayburn PA, Guileyardo JM, Stoler RC. Full Development of Consequences of Congenital Pulmonic Stenosis in Eighty-Four Years. The American Journal of Cardiology Apr 2017; 119( 8): 1284-1287.
102. Roberts WC, Grayburn PA, Hamman BL. Lipoma of the Mitral Valve. The American Journal of Cardiology Apr 2017; 119( 7): 1121- 1123.
103. Roberts WC, Kapoor P, Main ML, Guileyardo JM. Acute Aortic Dissection with Intussusception of the Partition between the True and False Channels Leading to Near Total Aortic Occlusion( True Aortic Stenosis). American Journal of Cardiology Jan 2017; 119( 2): 340-344.
104. Roberts WC, Sherwood M, Grayburn PA. Two causes for one patient for extremely low voltage on the electrocardiogram. Proceedings Baylor University Medical Center Apr 2017; 30( 2): 228-229.
86